Peptide handling
AOD-9604 reconstitution calculator
Reconstitution calculator for AOD-9604, prefilled for its 5 mg vials. Get the concentration, the dose volume and the U-100 syringe reading.
Start from a compound
Fills the vial size and a starting water volume. Only compounds with a citable range fill a dose.
The second is the question asked once the syringe is already filled, or when checking a vial someone else reconstituted.
1 mg = 1,000 mcg. Published figures are usually micrograms; vial labels are milligrams.
- Draw to
- 12 unitson a U-100 syringe
- Dose
- 300 mcg
- Dose volume
- 0.12 mL
- Concentration
- 2.5 mg/mL
- Per unit
- 25 mcg
- Doses per vial
- 16whole doses; a partial one is not counted
Shown on a 30-unit (0.3 mL) U-100 syringe, the smallest that holds this draw.
AOD-9604 — Reported practice — no study establishes this
No study establishes this range. It reflects reported practice and should be treated as the weakest possible basis for any figure. The prefilled dose is the low end of that range, daily.
Vial size and water volume are a starting point for the arithmetic, not a recommendation.
Adding more water makes the same dose a larger, easier-to-read mark on the syringe. It does not change how many doses the vial holds.
Vial sizes and starting volume
AOD-9604 is commonly supplied in 5 mg vials. The calculator opens on a 5 mg vial with 2 mL of bacteriostatic water — a starting point for the arithmetic, not a recommendation. Change either and everything recalculates.
That combination gives 2.5 mg/mL, so one insulin unit holds 25 mcg and a 300 mcg dose is 12 units.
What dose to enter
A range of 300–500 mcg per dose can be cited for AOD-9604, daily. The dose field opens at the low end of it.
Reported practice — no study establishes this
No study establishes this range. It reflects reported practice and should be treated as the weakest possible basis for any figure.
- Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone. — Preclinical metabolic study. Describes the lipolytic mechanism this compound is used for; per this entry's own tier note, it is ambiguous whether dosing here was established in humans.
- Effect of Intra-articular Injection of AOD9604 with or without Hyaluronic Acid in Rabbit Osteoarthritis Model. — Preclinical rabbit study. Rabbit osteoarthritis model — an unrelated indication and route, establishing no human dose.
- Interlaboratory agreement of insulin-like growth factor 1 concentrations measured by mass spectrometry (with discussion of AOD-9604 doping detection). — Analytical/doping-detection study. Concerns detection methodology, not a dosing schedule.
- Safety evaluation of AOD9604, a synthetic peptide for use in obesity. — Safety evaluation. Safety evaluation in the context of obesity use; per this entry's own tier note, whether the dosing evaluated was established in humans is ambiguous from the citation alone.
Related
- AOD-9604 — the product page, with its current batch.
- Bacteriostatic water — what goes in the vial.
- Peptide reconstitution calculator — the general version, with the blend and half-life calculators alongside it.
- Dosing reference — published schedules, each with the evidence behind it.
For research use only. This tool performs arithmetic on figures you supply — it is not medical guidance and does not recommend a dose for any compound.